Back to search results

Data Collection for Low-Grade Ovarian or Peritoneal Tumors

This study is collecting information to create a database for patients with low-grade ovarian or peritoneal tumors. Researchers will review your medical records and may collect residual tissue samples (biospecimens) from past procedures. The goal is to better understand these types of cancer, how they are treated, and what happens over time. This information could help develop better treatments in the future. The study is looking for women who have had certain low-grade ovarian or peritoneal tumors that have progressed to a higher-grade carcinoma.

Study design
This is an observational study aiming to collect data from approximately 2000 women. It involves reviewing medical records and collecting tissue samples.
What's involved
Your medical records will be reviewed, and residual tissue samples may be collected and stored. No specific visits or tests are mentioned.
Compensation
Not stated in the trial record.
Follow-up
Data collection on disease characterization, treatment, and outcomes will occur for up to 28 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT00488878

Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors

Recruiting
Not specifiedAll AgesObservational
M.D. Anderson Cancer Center
~2,000 participants
Updated 2026-08-10 on ClinicalTrials.gov
What's tested:Biospecimen CollectionElectronic Health Record Review

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Prospective and retrospective data collection on disease characterization, treatment, and outcomes
Measured over Up to 28 years
+2 more outcomes measured

Conditions

Low Grade Ovarian Serous Adenocarcinoma
Malignant Ovarian Neoplasm
Ovarian Carcinoma
Primary Peritoneal Carcinoma
Primary Peritoneal Low Grade Serous Adenocarcinoma
Psammocarcinoma

Explore related trials

Malignant Ovarian NeoplasmMalignant Peritoneal NeoplasmPsammocarcinoma

Where it's being run

1 sites across 1 states
Texas1

Study leadership

  • David M Gershenson · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Who to contact

Lisa Nathan
[email protected]
713-745-3837
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis:
Ovarian tumor of low malignant potential
Low-grade serous carcinoma of the ovary
Primary peritoneal tumor of low malignant potential
Low-grade serous carcinoma of the peritoneum
Psammocarcinoma

What this trial measures

  • Prospective and retrospective data collection on disease characterization, treatment, and outcomesUp to 28 years
  • Organization of clinical informationUp to 28 years

    Will be done in order to support multifaceted queries of patient characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with patient outcome.

  • Creation of a single data repository to integrate clinical information and research findingsUp to 28 years